Braidwell’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1M Buy
587,567
+241,100
+70% +$13.1M 0.93% 44
2026
Q1
$21.7M Buy
+346,467
New +$27.7M 0.73% 53
2024
Q4
Sell
-189,200
Closed -$15.9M 77
2024
Q3
$15.9M Buy
+189,200
New +$14.9M 0.45% 56
2023
Q4
Sell
-1,164,850
Closed -$61.5M 77
2023
Q3
$61.5M Buy
1,164,850
+447,800
+62% +$23.5M 1.94% 11
2023
Q2
$38.8M Buy
+717,050
New +$37.5M 1.27% 27

Other funds holding BSX

Braidwell's BSX Position: Q2 2026 in Review

Braidwell increased its Boston Scientific (BSX) stake by 70% in Q2 2026, buying an estimated $13.1M and bringing the position to 587,567 shares worth $25.1M. The position accounts for 0.93% of the portfolio, ranked #44.

Braidwell first reported a position in BSX in Q2 2023 and has held it in 5 quarters since. The position peaked at $61.5M in Q3 2023. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Braidwell held 587,567 shares of Boston Scientific worth $25.1M as of Q2 2026.
  • Braidwell bought 241,100 Boston Scientific shares in Q2 2026, an estimated $13.1M.
  • Boston Scientific made up 0.93% of Braidwell's portfolio in Q2 2026, its #44 holding.
  • Braidwell first reported a position in Boston Scientific in Q2 2023 and has held it in 5 quarters since.
  • Braidwell's Boston Scientific position peaked at $61.5M in Q3 2023.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.